Boston startup naps $18M to develop implant coatings |

Boston startup naps $18M to develop implant coatings

Semprus Scores $18M More to Help Improve Medical Devices (Xconomy)

MIT Spinout Semprus BioSciences Looks for Strong Bonds with Medical-Device Companies After Closing $8M Series A (Xconomy)

Semprus spun out of MIT biotech inventor Bob Langer’s lab in 2007, and was previously called SteriCoat.  The startup is developing surface technologies for medical devices that can help prevent infections or unhealthy blood clots, or promote tissue regeneration. Semprus is led by CEO David Lucchino.

Leave a Reply

Your email address will not be published. Required fields are marked *